Correlation Between Israel China and Clal Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Israel China and Clal Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Israel China and Clal Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Israel China Biotechnology and Clal Biotechnology Industries, you can compare the effects of market volatilities on Israel China and Clal Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Israel China with a short position of Clal Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Israel China and Clal Biotechnology.

Diversification Opportunities for Israel China and Clal Biotechnology

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Israel and Clal is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Israel China Biotechnology and Clal Biotechnology Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Biotechnology and Israel China is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Israel China Biotechnology are associated (or correlated) with Clal Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Biotechnology has no effect on the direction of Israel China i.e., Israel China and Clal Biotechnology go up and down completely randomly.

Pair Corralation between Israel China and Clal Biotechnology

Assuming the 90 days trading horizon Israel China Biotechnology is expected to generate 2.09 times more return on investment than Clal Biotechnology. However, Israel China is 2.09 times more volatile than Clal Biotechnology Industries. It trades about 0.35 of its potential returns per unit of risk. Clal Biotechnology Industries is currently generating about -0.34 per unit of risk. If you would invest  50,000  in Israel China Biotechnology on August 27, 2024 and sell it today you would earn a total of  12,000  from holding Israel China Biotechnology or generate 24.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Israel China Biotechnology  vs.  Clal Biotechnology Industries

 Performance 
       Timeline  
Israel China Biotech 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Israel China Biotechnology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong fundamental drivers, Israel China is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Clal Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Israel China and Clal Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Israel China and Clal Biotechnology

The main advantage of trading using opposite Israel China and Clal Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Israel China position performs unexpectedly, Clal Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Biotechnology will offset losses from the drop in Clal Biotechnology's long position.
The idea behind Israel China Biotechnology and Clal Biotechnology Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments